Integral Dental Launches New Test for Peri-Implant Disease

Integral Dental recently announced that it has developed a diagnostic test for Peri-implant disease, a disease related to dental implants and the tissues around them. This novel test is an important improvement in the diagnosis and treatment of peri-implantitis, which, if not addressed, results in implant loss and other complications.

Dental Software Market Size

Insights from Precedence Research shows that global dental software market size was estimated at US$ 1.80 billion in 2022 and it is expected to surpass around US$ 5.04 billion by 2032 with a registered CAGR of 10.90% from 2023 to 2032.

This newly developed diagnostic test is built upon modern biomarker technology to diagnose inflammation and infection at the peri-implant site. Specific biological markers involved in the test have helped dental specialists make a clear diagnosis of early-stage peri-implant disease. The test provides results in a relatively short time so that dentists make adequate decisions concerning a patient’s treatment. Conventional diagnostic approaches take longer or weeks to produce results, leading to delayed essential treatments.

Integral Dental’s test does not involve any intrusiveness in the general testing in a bid to ensure the patients do not feel any pain. This increase in patient experience whilst retaining diagnostic precision gives this approach value. It gives information on several biomarkers at the same time, which is helpful for the assessment of the oral health of a patient. This enables the practitioners to address the various issues involved in a comprehensive way because this analysis is detailed.

The peri-implant disease remains a threat in dentistry. Recent research has shown that between 30% and 50% of patients having dental implants may develop some type of implant-related complications between 5 to 10 years after implant placement. Screening is very helpful in avoiding the promotion of periodontitis to peri-implantitis, which leads to an increased number of lost tissues and implant failure.

Peri-Implant Disease Prevalence (2023)

Year	Percentage of Patients with Peri-Implant Disease	Percentage of Implant Failures Due to Peri-Implant Disease
2023	25%	10%

As the global number of dental implant surgeries reaches millions, there is a high need for standardized diagnostic tools to enhance patient safety and success. Integral Dental test means that the company is ready to dominate this new segment of dental diagnostics, competing with other diagnostic instruments in the market. The growth of personalized and preventive dental healthcare solutions aligns the company with its commitment to providing high-end patient care.

Overview of Dental Diagnostic Technologies

Company	Product Range	Focus Area
Integral Dental	Diagnostic Tests	Peri-Implant Disease
OralDNA Labs	Salivary Diagnostics	Oral Pathogens
BIOLASE	Laser Technology	Surgical & Diagnostic

Integral Dental extending a diagnostic test for the peri-implant disease is a significant revolution in dental technology. Through emphasis and investment in early identification and precise diagnosis, the company envisages to advance agenda in the maintenance of peri-implantitis. Techniques, including this particular test, are instrumental to the development of the foreseeable future dental services and the sustainability of dental implants. The aim that Integral Dental seeks to help realize better oral health care outcomes should be positively received in the dental fraternity and foster improved performance and experiences in the future years.

We’ve prepared a service to support you. Please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344